chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received influenza vaccine, FLUAD (65+) PFS 2020-21 injection. Developed a rash that spread from hands to arms, legs and neck.
Information has been received from a physician, via a company representative, concerning a 15 year old female patient who was vaccinated (date not specified) with a dose of Gardasil. Right after the shot was administered, the patient experienced "more than moderate itching" at the injection site. At the time of this report, the physician reported that the patient was recovering. The patient sought unspecified medical attention. The patient's two sisters also experienced the event as described above after vaccination with Gardasil (WAES 0703USA05417, 0703USA05418). Additional information has been requested.
Patient received Rabies Vaccine. After receiving vaccine, Patient became pale, diaphoretic, and fainted. Approximately 3 seconds after fainting patient awakened. She c/o chest pain. 911 was called. EMT evaluated patient. Patent declined transport to ED.
tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, the patient experienced COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine). On 24-May-2021, COVID-19 (tested positive for Covid 19 after receiving the 1st dose of the Moderna Vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, SARS-CoV-2 test: positive negative (Positive) Positive. On 24-May-2021, SARS-CoV-2 test: negative negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were reported. No treatment medication details was reported.  Follow-up received on 26JUN-2021 included no new information   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Initial Additional-1: No new information added
Whole arm and shoulder pain for about 30 mins after receiving vaccine. Pt sat in the booth until the pain subsided and pt was able to safely drive home
Vomiting; spike the fever; he has fever almost of high 104 degrees F; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent.  A 11 year-old male patient received bnt162b2 (BNT162B2), administration date 29Dec2021 12:00 (Batch/Lot number: unknown) as dose 2 (tris), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 29Dec2021 22:30, outcome "not recovered", described as "spike the fever; he has fever almost of high 104 degrees F"; DIARRHOEA (non-serious) with onset 29Dec2021 22:30, outcome "not recovered", described as "Diarrhea"; VOMITING (non-serious) with onset 01Jan2022, outcome "unknown", described as "Vomiting". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of diarrhoea.  Additional information: Reporter said her son (patient) was perfectly fine and was asymptomatic before and that right after he was okay. She reported that about 12 hours after administration (patient received his second dose at 12 pm), at 22:30-00:00, he spike a fever and developed diarrhoea. She thought the symptoms would resolve between 24-48 hours but "it's been close to 62 hours". She reported her son having a fever of 104 degree Fahrenheit last night and the diarrhoea" could not be controlled with Imodium, max dose and on the day of report in morning patient had vomiting.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Weird taste in mouth after 5 minutes, within 15 minutes throat tightness, and back of tongue swelling. Some difficulty swallowing. Kept having to clear my throat. Hoarseness in my voice began soon after. Was treated with liquid benadryl 50mg po and used my albuterol inhaler. Vitals were taken by vaccination center clinicians and staff. Symptoms began to alleviate once po benadryl began working. Took a longer acting antihistamine, Allegra when I got home. Had to take another dose of Benadryl later this afternoon.  Started itching all over body.
Information has been received from a consumer and a health professional concerning a 6 year old male with a penicillin allergy an allergy to gelatin and a history of an allergic reaction to a Kosher gelatin candy who on 23-AUG-2005, was vaccinated with a second subcutaneous dose in the right arm of MMR II (lot 647107/0464R(. Concomitant vaccines included a first dose of Varivax (lot 649643/0421R), a dose of PedvaxHib, a fifth intramuscular dose in the left arm of Infanrix (Lot # AC4B005AA) and a fourth intramuscular dose in the left arm of IPOL (Lot# y0343). There was no illness at the time of vaccination and no adverse events following prior vaccination. The patient's mother reported that in June 2005 the child had an allergic reaction with swelling from head to tow. The health care professional indicated that the child developed hives and itching all over the body. There was no shortness of breath. The Varivax was the only vaccine that the patient had not received in the past. Treatment included Benadryl, ice packs and oral prednisone. The patient recovered in June 2005. No product quality complaint was involved. Follow-up information from a physician indicated that on 23-AUG-2005, the patient left the office but referred in 10 minutes with an allergic reaction, described as flushed with itching especially on the feet and hands. There was no difficulty breathing. The patient was given Benadryl, 2 teaspoons and a cool compress. It was noted that the patient developed a few hives. The patient was sent out on Benadryl and oral prednisone. The patient was reported as recovered on 23-AUG-2005. Additional information has been requested.
Redness, swelling, warmth, streaking down arm + pain, tenderness + blistering + lymph node enlargement.
Patient was given moderna vaccine NDC 80777-275-05 labeled "Booster dose only" instead of the updated bivalent vaccine. Patient has not reported any adverse effects at this time.
She had a lot of pain after her first dose it went down from her arm to her lefts and hip,The pain also went to her shoulders and shoulder blades; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She had a lot of pain after her first dose it went down from her arm to her lefts and hip,The pain also went to her shoulders and shoulder blades) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (She had a lot of pain after her first dose it went down from her arm to her lefts and hip,The pain also went to her shoulders and shoulder blades). The patient was treated with IBUPROFEN for Pain in joint involving shoulder region, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (She had a lot of pain after her first dose it went down from her arm to her lefts and hip,The pain also went to her shoulders and shoulder blades) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient intakes  unknown thyroid medication for unspecified thyroid condition. Treatment with Ibuprofen taken to alleviate the symptoms experienced.
first dose of shingrix on  6 march 2020, never got the  2nd dose.; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 6th March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: Age at vaccination was not applicable to this report. No other details of patient available. Pharmacist reported that patient got first dose of shingrix on 6th March 2020. The patient never got the 2nd dose, which led to incomplete course of vaccination. The reporter asked about 2nd dose or to revaccinate. The reporter consented to follow up.
Patient had swelling and redness at injection site. Patient treated with doxycycline, prednisone, and BENADRYL. Swelling and redness gone per MD ofc. on 6/6/13.
pt devel myalgias in legs-spreading to upper body; also noted fever & prostration x 3 days; did not seek med attn; had redness, swelling @ inject site & soreness; c/o persistent hard knot @ inject site; exam has 1 cm hard, tender, discrete
Developed mild case of chicken pox. Approximately 20 lesions have developed on arms and legs.
Patient ran a fever that evening. The next morning (2/13/2016) he vomited and again that afternoon. The injection site was reddened (approx 1") and slightly raised.  Patient complained of pain and tenderness regarding whole left arm (8 on Wong Faces Scale). We couldn't touch it and he could not move it without pain. Mild swelling of reddened area. Mild fever (<100*F) throughout the day. Reddened area increased over the next few days to include his whole shoulder and 3/4 length of upper arm to elbow, wrapping around to underside of arm with mild swelling.  Pain and tenderness of that scale continued for 2 more days. Today, 2/16/2016 he reports a pain level of 4 out of 10 on the Wong Faces Scale. Reddening has decreased as has swelling.
COVId Vaccine Breakthrough CAse  Moderna Dose 1 2/25/21 (024M20A) Moderna Dose 2 3/25/21 (036A21A) COVID Positive 12/4/21  12/5/21: Patient is a 73-year-old female vaccinated for COVID-19 presents to ER with chief complaint of generalized fatigue associated with intermittent fevers, cough, shortness of breath and diarrhea for the past 4 days, patient reports she tested positive for COVID-19 yesterday (12/4), noted to be hypoxic upon EMS assessment with oxygen saturation of 85% on room air patient was placed on 3 L of supplemental oxygen.  Evaluations completed the emergency room noted for leukocytosis of 14.61, chest x-ray suggested atypical viral pneumonia, patient was treated with IV Rocephin, supplemental oxygen, Tylenol for fever.  12/9/21: Patient was admitted for COVID-19 pneumonia with respiratory failure initially required supplemental oxygen. She was started on Decadron 6 mg daily along with remdesivir.  She was covered with empiric ceftriaxone and azithromycin for possible superimposed bacterial pneumonia. Did have 1 of 2 blood cultures positive for coag-negative staph and was given vancomycin for short time.  Patient had gradual improvement in oxygen requirements and on the day of discharge felt improved.  Home oxygen evaluation was performed which showed she needed room air at rest and 2 L of oxygen with exertion.  She will finish 5 further days of Decadron and be discharged with COVID-19 at home program.
I experienced - and am still experiencing - neuropathy in my feet and hands. It is worse on left side, which is where my Pfizer vaccines were administered.  I felt a light pins and needles/tingling after 1st dose of the vaccine. One week after the second dose of the vaccine, it  became severe and persistent.
Vaccination side felt hard. Began to itch. Next morning severe itching and a blotchy  red spot where I had scratched.  Continued to itch. Applied Lidocaine anti itch gel and calamine lotion. No relief from itching..
after his second COIVD vaccine he has been experiencing stuffiness in only his left nostril; runny nose in just one nostril after receiving the 2nd dose.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "diabetic" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1,single.), for COVID-19 Immunization. The following information was reported: NASAL CONGESTION (non-serious), outcome "unknown", described as "after his second COIVD vaccine he has been experiencing stuffiness in only his left nostril"; RHINORRHOEA (non-serious), outcome "unknown", described as "runny nose in just one nostril after receiving the 2nd dose.". Therapeutic measures were not taken as a result of nasal congestion, rhinorrhoea.  Additional information: It was reported that on an unspecified date after his second COIVD vaccine the patient experienced stuffiness in only his left nostril. The patient reported that he had both shots of the Pfizer COVID vaccine. He reported that he saw on the news, that he could possibly be contacted for a booster shot. His wife told him he would be a good candidate for the booster shot. He wanted to know how he can get signed up for one. The patient reported that after his second COIVD vaccine he has been experiencing stuffiness in only his left nostril. The patient wanted to know more information about the booster shot of the covid-19 vaccine. He mentioned that he already took both doses of the vaccine but can't remember the exact date anymore. He also wanted to know if he already heard of someone who had a runny nose in just one nostril after receiving the 2nd dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Blood per his rectum, fussy, lethargic. 7/17/08-records received with report for DOS 5/24-5/26/08-DC DX: Intussusception. Presented to Ed with history of bloood per rectum. Fussy. Appetitie decreased. Constipated. One hard stool day before and vomtiting once.
Dizziness for 5 days, Migraine for 4  Body aches  4
The evening of the vaccine, my shoulder blade and back started to sting and hurting.  The pain was migrated into my trap muscle which lasted for 2 weeks.  I visited my doctor who said it might be from the injection itself.  The pain subsided a little but persisted for a couple of months.  I could use my arm but there was a constant state of weakness.  Towards the end of 2021, I saw improvement and it has since recovered.
Sore arm; fever; chills; body aches; fatigue; This is a spontaneous report from a contactable consumer (patient) or other non hcp.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date a the patient experienced sore arm, fever, chills, body aches and fatigue.  The outcome of all the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt had a dazed stare and was unresponsive.  Body was rigid and had right sided shaking which lasted 5 seconds, eyes were open. Slightly diaphoretic.  Patient became responsive and alert and oriented x 4 and stated he had been unaware of event, as if he had fallen asleep. V/S taken. BP 138/86 left arm, pulse 74, respirations 16 per minute, even and unlabored.  Patient was obserserved for over 30 minutes, given water and a snack.
My brain, uterus and left foot toes became inflamed.; My brain, uterus and left foot toes became inflamed.; My brain, uterus and left foot toes became inflamed.; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 61-year-old female patient (no pregnant) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EN5318) on 02Feb2021 18:30 on left arm at a single dose for covid-19 immunisation. Facility type vaccine was Doctor's office/urgent care. Medical history included chronic kidney disease (CKD), multiple personality disorder (MPD), blood pressure abnormal. Known allergies: several BP meds and cholesterol lowing. If other vaccine in four weeks was no. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), hydroxyurea, alopurinol. Patient experienced her brain, uterus and left foot toes became inflamed on 02Feb2021 19:30. It was like highlighting her problem areas. She was not sure to take the second shot. It happened after an hour after the shot and lasted within 5 minutes. No treatment was received. The outcome of the events was unknown. Events were considered non-serious per reporting other HCP.; Sender's Comments: The event Noninfective encephalitis most likelt an intercurrent condition and unrelated to suspect product bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE).
Patient is fully vaccinated. COVID positive on 5/9/2022. 67-year-old female, history of end-stage renal disease on peritoneal dialysis daily, CAD hypertension hyperlipidemia, COPD and CHF, oxygen dependent on 5 L presented to the ED with substernal chest pain and shortness of breath that was occurring all day yesterday that acutely worsened overnight while she was doing dialysis.no abdominal pain, no cough, no fatigue, no fever, no headache, no nausea, no numbness, no palpitations, no vomiting and no weakness.Adenocarcinoma of left lung. CXR revealed Infiltrative changes in the region of left upper lobe.  ESRD. Cr 11.03.Chronic respiratory failure with hypoxia.  NSTEMI.  Troponin level 3.18. SpO2 95%. Treatment: Solu=Medrol, oxygen, breathing treatments, Spiriva, metoprolol, dialysis, lasix, asprin. Admitted to hospice.  Expired on 6/2.
lower back pain/dense pain; reported arm pain after receiving the Pfizer Covid 19 Vaccine; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on 28Jul2021 as dose number unknown, single for COVID-19 immunization. Medical history included kidney infection. Caller reported a previous kidney infection. Was started on Bactrim (sulfamethoxazole). The patient's concomitant medications were not reported. The patient previously took sulfamethoxazole. Other Products were not provided. The patient experienced kidney infection (medically significant) and lower back pain/dense pain on an unspecified date in Jul2021. It was reported that, patient received her Pfizer Covid 19 Vaccine on 28Jul2021. She was feeling fine. She now had lower back pain. Caller reported a previous kidney infection. Was started on Bactrim (sulfamethoxazole). Patient enquired if she should contact her HCP or if the symptom might be related to the vaccine. Patient enquired if it was okay to take the Bactrim (sulfamethoxazole). Caller reported arm pain after receiving the Pfizer Covid 19 Vaccine and asked what's the time span that side effects were reported. Report was not related to a study or programme. Patient reported that, she got the shot yesterday and was feeling fine and asked if this was something she should look out for or if she should contact her HCP and her lower back had a dense pain. Therapeutic measures were taken as a result of kidney infection. The outcome of the events was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up. Follow-up attempts completed. No further information is expected.
Admission Date: 9/29/2022 Discharge Date: Oct 5, 2022  PRESENTING PROBLEM: Acute respiratory failure with hypoxia Primary spontaneous pneumothorax COVID-19 Pneumothorax on left   HOSPITAL COURSE: 75-year-old female with past medical history of hypertension, hyperlipidemia presented to the ER complaining worsening productive cough and shortness of breath with onset 9/25.  Patient had recent test positive COVID 19 on 9/27 recently had started Paxlovid.  After arrival, patient was needing 15 L non-rebreather new ER.  She was found to have a large sized left pneumothorax.  She had chest tube placed in the emergency department and she was admitted to the hospital with pulmonology consulted.  Also, she was started on remdesivir as well for COVID-19.  Patient's respiratory failure quickly resolved after chest tube placement.   After admission, she was evaluated by pulmonology who felt that her pneumothorax was exacerbated by COVID-19.  This is patient's 3rd pneumothorax recently in the last 2 months.  Pulmonology recommend that patient be transferred to hospital for cardiothoracic surgery evaluation.  After arrival to hospital, cardiothoracic surgery saw patient and recommended non operative management.  Cardiothoracic surgery felt patient to high risk given her active COVID-19 infection and recommended intervention pulmonology consult.  Interventional pulmonology evaluated. Chest tube was removed and outpatient pleurodesis was recommended.  She was discharged home with pulmonology follow up.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 12-JUN-2013, patient received improperly stored VARIVAX dose 2, from lot # H018451 expiry date 09-OCT-2014. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
No adverse event as of now. Wrong vaccine given. Patient does not meet age requirement for High Dose Fluzone. Pt was notified and denied any adverse effects at this time.